Search Results

Search Results for""
Introducing the Revolution Multi Material 3d Bioprinter Print with up to 10 (bio)materials Heated enclosure keeping cells warm Affordable, from €12,500 (Euro) £8,700 (GBP), Upgradable & Expandable
Read More
Based in San Diego, CA, Organovo is the only public company that operates in the field of human tissue 3D printing. Its bioprinter has already achieved some breakthrough results in the printing of live liver tissue that responds to drug stimuli. Bioprinting organs such as liver, kidney and skin for transplants is one of the great promises of additive manufacturing methods and it is usually explored most at a academic level, without real commercial applications in sight for at least the next 5 years. However Organovo's technology is viewed as viable by the scientific community and holds great potential.
Read More
Advanced Solutions, Inc. and its subsidiaries operate as a diversified technology company providing integrated software solutions and services allowing businesses to achieve more effective products, processes, technologies and ideas. The Company serves clients in the architecture, engineering, construction, manufacturing, material handling, retail and biomedical industries. Advanced Solutions leverages technology to improve business processes, product quality and customer satisfaction.
Read More
RegenHU is an innovative biomedical company located in Switzerland, belonging to the CPA Group SA. RegenHU acts as a biosystem architect exploiting new biomanufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. The company benefits from exclusive patented technologies resulting from many years of research within international universities and partners.
Read More
Swedish start up which manufacturers the CELLINK bioink, compatbile with most extrusion based 3D bioprinters on the market.CELLINK is the final puzzle piece in the 3D Bioprinting industry we all have been waiting for. CELLINK is a bioink that can universally be used on a wide range of 3D Bioprinters. CELLINK can also be used independently of any printing device, in case you want to perform simpler experiments of 3D cell culturing. The unique biocompatibility and printability of our bioink offers outstanding results that will take your research to the next level!The company also launched the INKREDIBLE 3D bioprinter, starting at $5,000
Read More
Skolokovo Research Center resident company producing Russia's first bioprinter
Read More

A new dimension to biomedical engineering

regenHU is an innovative biomedical company located in Switzerland, belonging to the CPA Group SAregenHU acts as a biosystem architect exploiting new biomanufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. regenHU benefits from exclusive patented technologies resulting from many years of research within international universities and partners.

Value Proposition

Advancements in medical Science, biology, cell-based therapies, as well as the ever increasing market entry barriers induced by biomedical product regulations and legislations, ask for innovative solutions to create biogical relevant tissue models. It is well known nowadays that these requirements can only be fulfilled if science is able to mimic natural morphologic environments of the third dimension.We provide the tools to enter the third dimension
Read More
Biomedical research is gravitating towards 3D cell culture models and tissue printing. At n3D, we sell kits and services for 3D cell culture. Our core technology is the magnetization of cells, which can then be directed using magnetic forces. In this manner, we can either levitate or bioprint cells. These cultures are faster to assemble than other systems and easier to handle with magnets without losing samples. Check out our products and our services for more information on our technology, and how we can help you!There is a growing push for biomedical and pharmaceutical research to transition towards three-dimensional (3D) cell culture models. Model selection is basically a choice between representation (animal testing) and throughput (in vitro cell culture). 3D cell culture brings the best of both worlds, but technical limitations in cost and handling have prevented its widespread use.To overcome these challenges, Nano3D Biosciences (n3D) has developed magnetic cell culture, where we magnetize cells using NanoShuttleTM-PL, and then rapidly print them into microtissues using magnetic force. This is an easy method for 3D cell culture that works with any cell type, making it ideal for biomedical research and high-throughput compound screening.We offer a wide product line for our technology with kits that are easy to use and fit seamlessly into existing cell culture workflows. We also provide services, in cell culture optimization or contract research, where we leverage our expertise in 3D cell culture to deliver quality results.At n3D, our goal is to develop our magnetic cell culture technology into the industry standard for 3D cell culture, with longer term focuses on personalized medicine and regenerative medicine.
Read More

An Emerging Tool for Science & Technology

3D printing has recently become popular because of its ease and speed to customise 3D designs and turn them into real physical objects. 3D scientific and biological printing takes it further by 3D printing living cells, tissues and other biomaterials such as bacteria, antibodies, antigens, bio-gels, medicine, food materials and bio-polymers.

Scientists and engineers around the world continue to explore and study how the arrangement and design of living cells and other bio- and non-bio materials using 2D and/or 3D bio-printing can bring great potentials and applications in fields such as research & development, diagnostics, personalised medicine and drug development and testing.


We are a group of enthusiastic scientists, engineers and entrepreneurs coming together to bring new and disruptive technologies and sciences to the world. Bio3D Technologies is the fruit of our research and efforts, and we are proud to be one of the world's bioprinting pioneers.Together, we have created world's first and Singapore's first true scientific and biological 3D printer with multiple print heads, modular design, nozzle-to-platform auto-alignment, remote viewing and control etc. We are also the first to integrate an anti-vibration levitating platform into a 3D printer.We hope to bring affordable and reliable bioprinting and microprinting technologies to every researcher and engineer for the advancement of science and technology.With the introduction of Bio3D Explorer, we made 3D bioprinting even more affordable and accessible. Once again, we created another world's first- a foldable bioprinter that can be transported around easily.
Read More
3Dynamic Systems is a Swansea University UK-based 3D-Bioprinting manufacturer offering the first commercial and affordable 3D-Bioprinting systems. Our 3D-Bioprinters stem from our teams success in engineering tissues using Bioprinting technology. Our aim is to bring affordable and reliable bioprinting technologies to scientists and engineers who carry out research in the field of tissue engineering. Researchers from across the world wanted a flexible 3D-Bioprinter that was easy to install, operate and which offers value for money. This is what we have produced, accessible 3D bioprinting technology. Now you can procure this technology. Every machine is made to order using the same high quality materials and precise control systems, which is based on years of research and development. Every system is made to the same high tolerances that we have aspired to since day one. With a durable steel superstructure our machines are built to last. Our Alpha and Omega 3D-Bioprinters are dynamic, adaptive and durable technologies which are easy to use, repeatable and precisely deposit biological materials in 3D. The ability to engineer 3D tissue systems gives researchers in the field a tool to perform repeatable research into the sphere of 3D-Bioprinting. Be it if you are working with stem cell systems, cancer research, antibodies, proteins and/or bacteria research. Our systems can aid you in depositing materials accurately and efficiency in 3D.
Read More
Aspect Biosystems is a Canadian biotechnology company founded in November, 2013. The company spun out from two internationally recognized research groups in engineering and medicine at the University of British Columbia. Aspect Biosystems is working towards a future where doctors determine which drugs work for their patients before prescribing them, where animals are no longer needed for the development of new therapeutics, and where lifesaving transplant organs are created, not harvested. To realise these goals, Aspect has developed a disruptive 3D bioprinting platform technology capable of creating living human tissues on demand.Our initial products aim to improve the predictive accuracy of the pre-clinical drug discovery process by providing the industry and researchers with the technology to create highly customized physiologically-relevant 3D human tissue models that they can employ in the development of new drugs. Aspect’s technology has the potential to drive a fundamental shift in the pharmaceutical industry, enabling the development of completely new therapeutics, and enabling pharma to test drugs they may have shelved in the past due to a lack of appropriate models. Furthermore, Aspect’s technology has the potential to significantly reduce the use of laboratory animals, supporting an industry wide mandate to reduce, refine and replace animal testing. Aspect has a long-term vision to expand beyond applications in drug development, by enabling Human Tissues on Demand™ for broad applications in the life sciences including regenerative medicine and organ transplantation.
Read More
The recently announced Regenovo is the latest in a line of medical grade 3D bioprinters that is still under development and showing promising results. Coming out of the Hanghou University of Science and Technology in the eastern Zhejiang Province of China, the Regonovo has already produced numerous gelatinous, semi-transparent 3D printed ears, kidneys and various other conglomerations of cells in sterile environments. The printer uses medical polymers, live cells, inorganic and hydrogel materials to create a scaffold from which cells are cultured to create living tissue.
Read More
EBERS develops, manufactures and commercializes devices for research in cell culture, with special emphasis in the field of bioreactors and culture chambers for tissue engineering. Such bioreactors try to reproduce in an in-vitro culture environment some of the conditions which cells experience when growing in-vivo by using two different approaches: the application of controlled flow rates or the direct deformation of the scaffolds in which cells are seeded.The TEB series bioreactors allows applying a wide variety of flow profiles on the cultures. Used in combination with any of the available EBERS culture chambers, it allows creating both perfusion and perifusion conditions to culture cells on porous bone-type scaffolds as well as on cylindrical vessel-type scaffolds. The TC-3 bioreactor allows applying direct compression on the scaffolds to simulate in the culture the deformation occurring in the in-vivo tissues. Tension and compression can be alternatively applied to simulate the growing conditions in ligament, tendon or bone scaffolds. Moreover, our experienced engineering offers a consultancy service for the adaptation bioreactors and culture chambers to the particular demands of each researcher.As a crucial part of the company's strategy, we currently continue developing new systems for cell culture. We kindly invite you to surf our web for information on our products or to contact us for more specific information! 
Read More
BioBots is the 3D printer for biology. We are eliminating the organ waiting list to save tens of thousands of lives very year. We do this by building 3D bioprinter & accompanying printer cartridges that are accessible to both researchers at the frontier of regenerative medicine and non-specialists, such as high school biology teachers. By making this technology available and creating a community of users, we are lowering the barrier to entry into the field of regenerative medicine injecting a new dose of innovation into health care.
Read More
REGEMAT 3D is a biotech company focused on regenerative medicine and pioneer in a new and promising area called bioprinting, that uses 3D printing technologies for regenerative therapies.We provide bioprinting solutions for the community. We will support you to generate IP. We promote the creation of an open community to boost the clinical applications of bioprinting.
Read More
Nanoscribe GmbH, located in Eggenstein-Leopoldshafen near Karlsruhe, Germany, offers 3D printers for the micro- and nanometer scale as well as photoresists and process solutions tailored to specific application areas. Nanoscribe has established itself in this field as the technological and global market leader with its laser lithographic processes. Our 3D lithography systems are spread throughout Europe, Asia, North America as well as Australia. The performance of the groundbreaking Photonic Professional GT system generation was emphasized in February 2014 by being awarded a Prism Award in San Francisco, the "Oscar of Photonics" in the category "Advanced Manufacturing".
Read More
Poietis is a biotechnology company whose mission is to support Researchers and Physicians in the emergence of personalized medicine by providing innovative solutions based on 4D Bioimprinting technology of biological tissues .Incubated in the Incubateur Régional d''Aquitaine (Aquitaine Regional Incubator) between 2012 and 2014, and winner of the 2014 ILab Contest (French National Competition for Innovative start-up Creation of the Ministry of Research, Creation-Development category), Poietis is the result of nearly ten years of research at the INSERM and the Bordeaux University on the development of new approaches of tissue engineering.As a young and innovative company, Poietis, created in September 2014, obtained from the University of Bordeaux, INSERM and the SATT Aquitaine Science Transfert® office the exclusive worldwide license on patents associated with the Laser-Assisted Bioimprinting technology (more info here).

Laser-Assisted Bioprinting

The development and manufacture of biological tissues are major socio-economic issues valued at 15 billion dollars in 2014 and is expected to double by 2018. Applications of these tissues concern both the industrial sector (cosmetics and pharmaceuticals) and regenerative medicine.To cope with the limitations of conventional methods of tissue engineering, BioPrinting uses the principles of 3D printing, and so proceeds from the assembly layer – by – layer, of the constituents of the biological tissues(such as cells and the extracellular matrix ) in organizations (patterns) predefined by digital design.Laser-Assisted Bioprinting, as opposed to the conventional methods of tissue engineering and extrusion-based bioprinting, allows 3D positioning of cells with micrometric resolution and unmatched precision. It currently is the highest resolution bioprinting technology.
Read More

The Business of 3D Printing is Evolving

Don't miss out on opportunities: enter your email to receive news,
updates and exclusive offers directly to your inbox

This information will never be shared with third parties